Original Research
Published on 23 Jun 2025
BRICS sequential therapeutic regimen as first-Line treatment for PD-L1-negative metastatic non-small cell lung cancer patients harboring EGFR/ALK wild-type status: a retrospective study
in Cancer Immunity and Immunotherapy
- 145 views